Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)

Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)

US Patent 11421036 · Granted Aug 23, 2022

Estimated economic value: $405,902,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Compositions monovalent for CD28 binding and methods of use2024
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Methods for treating skin infection by administering an IL-4R antagonist2023
Methods for treating allergy and enhancing allergen-specific immunotherapy by ad2022
Method of treating an allergy with allergen-specific monoclonal antibodies2022
Method of treating an allergy with allergen-specific monoclonal antibodies2022